FLT3 and acute myeloid leukemia: To comprehensively explore the impact of concomitant genetic patterns to sorafenib efficacy in FLT3-ITD AML patients undergoing allo-HSCT, we herein perform a multi-center, exploratory, cohort study in patients with FLT3-ITD AML undergoing allo-HSCT.